Structure |
Chemical Name |
CAS |
MF |
![alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride](/CAS/20150408/GIF/104743-23-9.gif) |
alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride |
104743-23-9 |
C12H20ClNO |
![N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide](/CAS/20150408/GIF/177216-32-9.gif) |
N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide |
177216-32-9 |
C18H25N5O7 |
![5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1)](/CAS/20180808/GIF/64372-43-6.gif) |
5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) |
64372-43-6 |
C21H23BrFNO5 |
![(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine](/CAS/20150408/GIF/1070876-09-3.gif) |
(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine |
1070876-09-3 |
C28H26N6S2 |
![(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate](/CAS/20150408/GIF/1187479-72-6.gif) |
(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate |
1187479-72-6 |
C29H45BN2O5 |
![Posaconazole iMpurity 7](/CAS/20211123/GIF/2180759-84-4.gif) |
Posaconazole iMpurity 7 |
2180759-84-4 |
C37H42F2N8O4 |
![Intedanib Impurity](/CAS/20210305/GIF/2243396-74-7.gif) |
Intedanib Impurity |
2243396-74-7 |
C31H32N6O6 |
![Donepezil Impurity 3](/CAS/20180703/GIF/1023500-88-0.gif) |
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
![Fesoterodine Related Impurity 4](/CAS/20200515/GIF/214601-12-4.gif) |
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
![Prasugrel Impurity 14 Maleate](/CAS/20180808/GIF/1373350-60-7.gif) |
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
![Sofosbuvir Impurity 32](/CAS/20180808/GIF/1157884-58-6.gif) |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
![Torsemide Related Compound 1](/CAS/20200515/GIF/947327-54-0.gif) |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
![Vortioxetine Impurity 3](/CAS/20180808/GIF/508233-82-7.gif) |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
![CYCLOPENTYL BENZOATE](/CAS/20180703/GIF/32651-38-0.gif) |
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
![4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID](/CAS/GIF/31166-29-7.gif) |
4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID |
31166-29-7 |
C5H2Cl2O2S |
![N,O-Dibenzylated formoterol](/CAS/GIF/43229-70-5.gif) |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
![Entacapone](/) |
Entacapone |
|
|
![nifedipine iMpurity](/CAS/20180703/GIF/CB93033129.gif) |
nifedipine iMpurity |
|
C19H22N2O6 |
![Linagliptin Impurity A](/) |
Linagliptin Impurity A |
|
|
![Dehydropitavastatin ethyl ester](/CAS/20210111/GIF/254452-91-0.gif) |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
![(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide](/CAS/20180703/GIF/357338-13-7.gif) |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
![Linagliptin Impurity V](/) |
Linagliptin Impurity V |
|
|
![methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate](/CAS/20180703/GIF/1181267-33-3.gif) |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
![(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol](/CAS/20180703/GIF/150194-52-8.gif) |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
![Etoricoxib Impurity 18](/) |
Etoricoxib Impurity 18 |
|
|
![Ibrutinib Impurity 4](/CAS/20210111/GIF/1807619-68-6.gif) |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
![Imatinib Impurity 3](/) |
Imatinib Impurity 3 |
|
|
![Mirabegron Impurity 16](/) |
Mirabegron Impurity 16 |
|
|
![Olaparib Impurity 2](/) |
Olaparib Impurity 2 |
|
|
![Sofosbuvir Impurity 7](/CAS/20200611/GIF/1884385-12-9.gif) |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
![Vonoprazan Impurity 3](/CAS/20200611/GIF/928325-41-1.gif) |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
![Cinacalcet Impurity 22](/) |
Cinacalcet Impurity 22 |
|
|
![Dapagliflozin Impurity C](/) |
Dapagliflozin Impurity C |
|
|
![Dasatinib Impurity E](/) |
Dasatinib Impurity E |
|
|
![Ixazomib Impurity](/) |
Ixazomib Impurity |
|
|
![Nevirapine Impurity](/) |
Nevirapine Impurity |
|
|
![Omarigliptin Impurity](/CAS/20210111/GIF/1819364-01-6.gif) |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
![Palbociclib Impurity 8](/CAS/20180808/GIF/827022-31-1.gif) |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
![Sitagliptin EP Impurity C](/CAS/20180808/GIF/1345822-86-7.gif) |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
![Trifluridine Impurity](/) |
Trifluridine Impurity |
2086328-10-9 |
|
![Valsartan related compound H](/) |
Valsartan related compound H |
|
|
![Vildagliptin Related Compound H](/CAS/20200611/GIF/2253194-13-5.gif) |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
![Moxifloxacin Impurity 7](/) |
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
![Merariveron impurity D](/CAS/GIF/CB93053655.gif) |
Merariveron impurity D |
|
C26H28N6O3S2 |
![Cefazolin impurity E](/) |
Cefazolin impurity E |
|
|
![Lamivudine Impurity Mixture](/) |
Lamivudine Impurity Mixture |
|
|
![Rifaximin impurity B](/CAS/20211123/GIF/1351775-04-6.gif) |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
![4-(3-(Piperidin-1-yl)propoxy)benzoic acid](/CAS/20180703/GIF/767286-87-3.gif) |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
![5-Chloro-3-sulfino-2-thiophenecarboxylic acid](/CAS/20180703/GIF/187746-97-0.gif) |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
![methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20180703/GIF/CB93116219.gif) |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
![Isavuconazole Impurity 11](/CAS/20211123/GIF/2732924-99-9.gif) |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
![34-Methylcyanocobalamin](/CAS/20210111/GIF/38218-51-8.gif) |
34-Methylcyanocobalamin |
38218-51-8 |
C64H90CoN14O14P |
![Empagliflozin Impurity D](/) |
Empagliflozin Impurity D |
|
|
![Ipragliflozin Impurity 2](/) |
Ipragliflozin Impurity 2 |
|
|
![Nicergoline EP impurity F](/) |
Nicergoline EP impurity F |
|
|
![Mirabegron Impurity 4](/) |
Mirabegron Impurity 4 |
|
|
![Bisoprolol EP Impurity D](/CAS/20180629/GIF/1225195-71-0.gif) |
Bisoprolol EP Impurity D |
1225195-71-0 |
C26H40N2O5 |
![Febuxostat Descyano Impurity](/CAS/20180808/GIF/1206550-99-3.gif) |
Febuxostat Descyano Impurity |
1206550-99-3 |
C15H17NO3S |
![(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one](/CAS/20200119/GIF/14639-79-3.gif) |
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one |
14639-79-3 |
C19H28O |
![Cefuroxime Sodium Impurity](/CAS/20180629/GIF/CB13119214.gif) |
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
![2-Bromo (S)-Carbidopa](/CAS/20180808/GIF/43197-33-7.gif) |
2-Bromo (S)-Carbidopa |
43197-33-7 |
C10H13BrN2O4 |
![Eliglustat intermediate 3](/CAS/20200611/GIF/491833-26-2.gif) |
Eliglustat intermediate 3 |
491833-26-2 |
C23H28N2O5 |
![Aztreonam Impurity B](/CAS/20180629/GIF/102586-36-7.gif) |
Aztreonam Impurity B |
102586-36-7 |
C13H19N5O6S |
![Olopatadine impurity](/) |
Olopatadine impurity |
|
|
![Voriconazole Impurity 8](/CAS/20210305/GIF/239807-03-5.gif) |
Voriconazole Impurity 8 |
239807-03-5 |
C16H14F3N5O |
![Caspofungin impurity 3](/) |
Caspofungin impurity 3 |
|
|
![Plerixafor Impurity D](/) |
Plerixafor Impurity D |
|
|
![Cefuroxime impurity 1](/CAS/20200119/GIF/CB13127930.gif) |
Cefuroxime impurity 1 |
|
C16H16N4O8S |
![Vonoprazan Impurity 9](/) |
Vonoprazan Impurity 9 |
|
|
![Sitagliptin IMpurity 5](/) |
Sitagliptin IMpurity 5 |
|
|
![Brexpiprazole Impurity3](/) |
Brexpiprazole Impurity3 |
|
|
![Levetiracetam impurity 5](/CAS/20200611/GIF/1543300-90-8.gif) |
Levetiracetam impurity 5 |
1543300-90-8 |
C9H17NO4 |
![Levosimendan Impurity 2](/CAS/20210111/GIF/103416-88-2.gif) |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
![Famotidine EP Impurity A](/CAS/20180703/GIF/88061-72-7.gif) |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |
![Meloxicam EP Impurity D](/CAS/20180808/GIF/1331636-17-9.gif) |
Meloxicam EP Impurity D |
1331636-17-9 |
C16H17N3O4S2 |
![Erythromycin Impurity](/CAS/20210111/GIF/40554-78-7.gif) |
Erythromycin Impurity |
40554-78-7 |
C37H65NO12 |
![Fluconazole EP Impurity I](/CAS/20180808/GIF/150168-54-0.gif) |
Fluconazole EP Impurity I |
150168-54-0 |
C13H14BrF2N7O |
![1-benzyl-2-methyl-1H-imidazole-carbaldehyde](/CAS/20180703/GIF/39269-74-4.gif) |
1-benzyl-2-methyl-1H-imidazole-carbaldehyde |
39269-74-4 |
C12H12N2O |
![Sacubitril Impurity](/CAS/20200611/GIF/1015037-46-3.gif) |
Sacubitril Impurity |
1015037-46-3 |
C23H27NO4 |
![Desloratadine Impurity](/CAS/20210111/GIF/50603-12-8.gif) |
Desloratadine Impurity |
50603-12-8 |
C20H21N |
![Olaparib Impurity H](/) |
Olaparib Impurity H |
|
|
![Brexpiprazole Impurity B](/) |
Brexpiprazole Impurity B |
|
|
![Dapoxetine iMpurity 6](/) |
Dapoxetine iMpurity 6 |
|
|
![Irbesartan Impurity 4](/CAS/20200401/GIF/CB93127103.gif) |
Irbesartan Impurity 4 |
|
C25H28N6O |
![2-cyclopentylidene-2-phenylacetic acid](/CAS/20200401/GIF/CB93127224.gif) |
2-cyclopentylidene-2-phenylacetic acid |
|
C13H14O2 |
![Cabozantinib impurity B](/) |
Cabozantinib impurity B |
|
|
![Metoprolol IMpurity 3](/CAS/20200401/GIF/CB93127587.gif) |
Metoprolol IMpurity 3 |
|
C15H25NO3 |
![Mirabegron Impurity 1](/) |
Mirabegron Impurity 1 |
|
|
![Desfluoro Pitavastatin Calcium](/CAS/20200515/GIF/847849-67-6.gif) |
Desfluoro Pitavastatin Calcium |
847849-67-6 |
C25H25NO4 |
![Plerixafor](/CAS/20200611/GIF/548488-49-9.gif) |
Plerixafor |
548488-49-9 |
C12H23F3N4O |
![Vonoprazan Impurity 10](/) |
Vonoprazan Impurity 10 |
|
|
![Vonoprazan Impurity 5](/) |
Vonoprazan Impurity 5 |
|
|
![Sitagliptin IMpurity 1](/) |
Sitagliptin IMpurity 1 |
|
|
![Etoricoxib Impurity 7](/) |
Etoricoxib Impurity 7 |
|
|
![Ezetimibe Impurity D](/) |
Ezetimibe Impurity D |
|
|
![Erlotinib Imp.18](/) |
Erlotinib Imp.18 |
|
|
![Ezetimibe (RSS)-Isomer](/CAS/20180703/GIF/1478664-18-4.gif) |
Ezetimibe (RSS)-Isomer |
1478664-18-4 |
C24H21F2NO3 |